ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,0804
-0,12%
Bitcoin
69.406,54
0,11%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. PainReform Ltd (PRFX)

  7. PainReform Ltd (PRFX) News

PRFX

PainReform (PRFX)

PainReform Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PRFX
DatumZeitQuelleÜberschriftSymbolFirma
31/05/202422h24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
31/05/202422h15GlobeNewswire Inc.PainReform Announces Receipt of Nasdaq Minimum Bid Price NotificationNASDAQ:PRFXPainReform Ltd
15/05/202422h05GlobeNewswire Inc.PainReform Provides Business Update for the First Quarter of 2024NASDAQ:PRFXPainReform Ltd
08/05/202414h30GlobeNewswire Inc.PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.comNASDAQ:PRFXPainReform Ltd
18/04/202420h19GlobeNewswire Inc.PainReform Announces Closing of $4 Million Public OfferingNASDAQ:PRFXPainReform Ltd
16/04/202414h00GlobeNewswire Inc.PainReform Announces Pricing of $4 Million Public OfferingNASDAQ:PRFXPainReform Ltd
09/04/202415h00GlobeNewswire Inc.PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing ConditionsNASDAQ:PRFXPainReform Ltd
02/04/202414h30GlobeNewswire Inc.PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in BunionectomyNASDAQ:PRFXPainReform Ltd
07/03/202423h25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
01/03/202422h34Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:PRFXPainReform Ltd
01/03/202414h09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
01/03/202414h00GlobeNewswire Inc.PainReform Provides Year-End Business UpdateNASDAQ:PRFXPainReform Ltd
29/02/202422h37Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PRFXPainReform Ltd
22/01/202414h30GlobeNewswire Inc.PainReform to Present at the Microcap Conference in Atlantic CityNASDAQ:PRFXPainReform Ltd
22/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRFXPainReform Ltd
19/01/202422h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRFXPainReform Ltd
12/01/202422h15Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PRFXPainReform Ltd
03/01/202414h36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
03/01/202414h30GlobeNewswire Inc.PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain ReliefNASDAQ:PRFXPainReform Ltd
27/12/202322h04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRFXPainReform Ltd
27/12/202322h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
27/12/202300h00GlobeNewswire Inc.PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross ProceedsNASDAQ:PRFXPainReform Ltd
15/11/202322h09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
15/11/202322h05GlobeNewswire Inc.PainReform Provides Business Update for the Third Quarter of 2023NASDAQ:PRFXPainReform Ltd
11/09/202314h41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
11/09/202314h30GlobeNewswire Inc.PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master FileNASDAQ:PRFXPainReform Ltd
07/09/202316h00GlobeNewswire Inc.PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, HungaryNASDAQ:PRFXPainReform Ltd
05/09/202322h16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRFXPainReform Ltd
05/09/202314h30GlobeNewswire Inc.PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York CityNASDAQ:PRFXPainReform Ltd
05/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRFXPainReform Ltd
 Showing the most relevant articles for your search:NASDAQ:PRFX

Kürzlich von Ihnen besucht

TG
NOV
Novo Nordisk
CCOM
US500
US 500
USOTC
DTEGY
Deutsche Telekom (QX)
DBI
SDXP
SDAX
AMEX
XLE
Energy Select Sector SPDR
TG
ALV
Allianz
TG
BAS
BASF
USOTC
ADDYY
Adidas (QX)
NYSE
DIS
Walt Disney
TG
LHA
Deutsche Lufthansa
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
NYSE
KO
Coca Cola
DBI
TDXP
Tec DAX
TG
432
Arbor Metals
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten